Search Results - Thomas Ebensen

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing Ca... by Thomas Ebensen, Andrea Arntz, Kai Schulze, Andrea Hanefeld, Carlos A. Guzmán, Regina Scherließ

    Published in Pharmaceutics (2023-04-01)
    Get full text
    Article


  2. 2

    IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation by Ahmed E. I. Hamouda, Kai Schulze, Thomas Ebensen, Carlos Alberto Guzmán, Darío Lirussi

    Published in Pharmaceutics (2022-12-01)
    Get full text
    Article


  3. 3

    Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG by Maria Victoria Sanchez, Thomas Ebensen, Kai Schulze, Diego Esteban Cargnelutti, Eduardo A. Scodeller, Carlos A. Guzmán

    Published in Pharmaceutics (2023-03-01)
    Get full text
    Article


  4. 4

    Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression by Neha Vashist, Neha Vashist, Stephanie Trittel, Thomas Ebensen, Benedict J. Chambers, Carlos A. Guzmán, Peggy Riese

    Published in Frontiers in Immunology (2018-03-01)
    Get full text
    Article


  5. 5

    Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate by Moritz Winterhoff, Fangfang Chen, Nishika Sahini, Thomas Ebensen, Maike Kuhn, Volkhard Kaever, Heike Bähre, Frank Pessler

    Published in Metabolites (2021-04-01)
    Get full text
    Article


  6. 6

    Cyclic Di-Adenosine Monophosphate: A Promising Adjuvant Candidate for the Development of Neonatal Vaccines by Darío Lirussi, Sebastian Felix Weissmann, Thomas Ebensen, Ursula Nitsche-Gloy, Heiko B. G. Franz, Carlos A. Guzmán

    Published in Pharmaceutics (2021-02-01)
    Get full text
    Article


  7. 7

    Immune responses following neonatal vaccination with conserved F4 fragment of VtaA proteins from virulent Glaesserella parasuis adjuvanted with CAF®01 or CDA by Sergi López-Serrano, Yasser S. Mahmmod, Dennis Christensen, Thomas Ebensen, Carlos A. Guzmán, Fernando Rodríguez, Joaquim Segalés, Virginia Aragón

    Published in Vaccine: X (2023-08-01)
    Get full text
    Article


  8. 8

    Prophylactic Multi-Subunit Vaccine against <i>Chlamydia trachomatis:</i> In Vivo Evaluation in Mice by Christian Lanfermann, Sebastian Wintgens, Thomas Ebensen, Martin Kohn, Robert Laudeley, Kai Schulze, Claudia Rheinheimer, Johannes H. Hegemann, Carlos Alberto Guzmán, Andreas Klos

    Published in Vaccines (2021-06-01)
    Get full text
    Article


  9. 9

    Immune Responses to Pandemic H1N1 Influenza Virus Infection in Pigs Vaccinated with a Conserved Hemagglutinin HA1 Peptide Adjuvanted with CAF<sup>®</sup>01 or CDA/αGalCerMPEG by Sergi López-Serrano, Lorena Cordoba, Mónica Pérez-Maillo, Patricia Pleguezuelos, Edmond J. Remarque, Thomas Ebensen, Carlos A. Guzmán, Dennis Christensen, Joaquim Segalés, Ayub Darji

    Published in Vaccines (2021-07-01)
    Get full text
    Article


  10. 10

    Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids by Pavlos C. Englezou, Cedric Sapet, Thomas Démoulins, Panagiota Milona, Thomas Ebensen, Kai Schulze, Carlos-Alberto Guzman, Florent Poulhes, Olivier Zelphati, Nicolas Ruggli, Kenneth C. McCullough

    Published in Molecular Therapy: Nucleic Acids (2018-09-01)
    Get full text
    Article


  11. 11

    Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection by Andrés Sanchez Alberti, Augusto E. Bivona, Natacha Cerny, Kai Schulze, Sebastian Weißmann, Thomas Ebensen, Celina Morales, Angel M. Padilla, Silvia I. Cazorla, Rick L. Tarleton, Carlos A. Guzmán, Emilio L. Malchiodi

    Published in npj Vaccines (2017-04-01)
    Get full text
    Article


  12. 12

    Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice by Thomas Ebensen, Jennifer Debarry, Gabriel K. Pedersen, Gabriel K. Pedersen, Gabriel K. Pedersen, Paulina Blazejewska, Sebastian Weissmann, Kai Schulze, Kenneth C. McCullough, Rebecca J. Cox, Rebecca J. Cox, Rebecca J. Cox, Carlos A. Guzmán

    Published in Frontiers in Immunology (2017-09-01)
    Get full text
    Article


  13. 13

    Correction: Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. by Aaqib Sohail, Azeem A Iqbal, Nishika Sahini, Fangfang Chen, Mohamed Tantawy, Syed F H Waqas, Moritz Winterhoff, Thomas Ebensen, Kristin Schultz, Robert Geffers, Klaus Schughart, Matthias Preusse, Mahmoud Shehata, Heike Bähre, Marina C Pils, Carlos A Guzman, Ahmed Mostafa, Stephan Pleschka, Christine Falk, Alessandro Michelucci, Frank Pessler

    Published in PLoS Pathogens (2022-11-01)
    Get full text
    Article


Search Tools: